Dimerization of MLL fusion proteins immortalizes hematopoietic cells - PubMed (original) (raw)
Dimerization of MLL fusion proteins immortalizes hematopoietic cells
Mary Ellen Martin et al. Cancer Cell. 2003 Sep.
Free article
Abstract
MLL fusion proteins are leukemogenic, but their mechanism is unclear. Induced dimerization of a truncated MLL immortalizes bone marrow and imposes a reversible block on myeloid differentiation associated with upregulation of Hox a7, a9, and Meis1. Both dimerized MLL and exon-duplicated MLL are potent transcriptional activators, suggesting a link between dimerization and partial tandem duplication of DNA binding domains of MLL. Dimerized MLL binds with higher affinity than undimerized MLL to a CpG island within the Hox a9 locus. However, MLL-AF9 is not dimerized in vivo. The data support a model in which either MLL dimerization/exon duplication or fusion to a transcriptional activator results in Hox gene upregulation and ultimately transformation.
Similar articles
- Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.
Milne TA, Martin ME, Brock HW, Slany RK, Hess JL. Milne TA, et al. Cancer Res. 2005 Dec 15;65(24):11367-74. doi: 10.1158/0008-5472.CAN-05-1041. Cancer Res. 2005. PMID: 16357144 - Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias.
So CW, Lin M, Ayton PM, Chen EH, Cleary ML. So CW, et al. Cancer Cell. 2003 Aug;4(2):99-110. doi: 10.1016/s1535-6108(03)00188-0. Cancer Cell. 2003. PMID: 12957285 - Establishment of an inducible expression system of chimeric MLL-LTG9 protein and inhibition of Hox a7, Hox b7 and Hox c9 expression by MLL-LTG9 in 32Dcl3 cells.
Joh T, Hosokawa Y, Suzuki R, Takahashi T, Seto M. Joh T, et al. Oncogene. 1999 Jan 28;18(4):1125-30. doi: 10.1038/sj.onc.1202400. Oncogene. 1999. PMID: 10023690 - MLL: a histone methyltransferase disrupted in leukemia.
Hess JL. Hess JL. Trends Mol Med. 2004 Oct;10(10):500-7. doi: 10.1016/j.molmed.2004.08.005. Trends Mol Med. 2004. PMID: 15464450 Review. - Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins.
Ayton PM, Cleary ML. Ayton PM, et al. Oncogene. 2001 Sep 10;20(40):5695-707. doi: 10.1038/sj.onc.1204639. Oncogene. 2001. PMID: 11607819 Review.
Cited by
- Multiple clonal MLL fusions in a patient receiving CHOP-based chemotherapy.
Shih SJ, Fass J, Buffalo V, Lin D, Singh SP, Diaz MO, Vaughan AT. Shih SJ, et al. Br J Haematol. 2012 Oct;159(1):50-7. doi: 10.1111/j.1365-2141.2012.09248.x. Epub 2012 Jul 30. Br J Haematol. 2012. PMID: 22845170 Free PMC article. - Identification of a chromosomal breakpoint and detection of a novel form of an MLL-AF17 fusion transcript in acute monocytic leukemia with t(11;17)(q23;q21).
Suzukawa K, Shimizu S, Nemoto N, Takei N, Taki T, Nagasawa T. Suzukawa K, et al. Int J Hematol. 2005 Jul;82(1):38-41. doi: 10.1532/IJH97.05025. Int J Hematol. 2005. PMID: 16105757 - Linking the epigenetic 'language' of covalent histone modifications to cancer.
Hake SB, Xiao A, Allis CD. Hake SB, et al. Br J Cancer. 2004 Feb 23;90(4):761-9. doi: 10.1038/sj.bjc.6601575. Br J Cancer. 2004. PMID: 14970850 Free PMC article. Review. - Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6.
Liedtke M, Ayton PM, Somervaille TC, Smith KS, Cleary ML. Liedtke M, et al. Blood. 2010 Jul 8;116(1):63-70. doi: 10.1182/blood-2009-09-243386. Epub 2010 Apr 15. Blood. 2010. PMID: 20395419 Free PMC article. - PAFc, a key player in MLL-rearranged leukemogenesis.
Tan J, Muntean AG, Hess JL. Tan J, et al. Oncotarget. 2010 Oct;1(6):461-5. doi: 10.18632/oncotarget.181. Oncotarget. 2010. PMID: 21037944 Free PMC article.